Hey Buildit, Yes, #1 is what we are concerned wit

Hey Buildit,
Yes, #1 is what we are concerned with. And #2 was already stated by someone here after talking with Joe, that the appraisal company is putting together their valuation and will use the peer review to adjust that valuation, so I take that as meaning the peer review is holding up the final valuation.

Quote:

---

I think there are 2 things here:

1) IF the vaccine is still moving forward, then there is no harm done by this lack of vaccine information, other than added stress in the short term.

2) There isn't necessarily a tie between the peer review and the NGIO listing. Those could certainly be separate items, where NGIO list moves forward, and vaccine peer review comes out after, supporting the list price and drawing attention. Also keep in mind that the peer review could already be months into the process.


Read More: https://investorshangout.com/post/newpost/622...z6gL4G41ma

---

Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.